Analysis of predefined safety events across spesolimab trials in dermatological and non-dermatological conditions
Version 2 2025-01-14, 11:55
Version 1 2025-01-14, 10:56
media
posted on 2025-01-14, 11:55 authored by Adis Journals on Behalf of, Kenneth Gordon, Yayoi Tada, Milan J. Anadkat, Siew Eng Choon, Boni Elewski, Jonathan Barker, Arash Mostaghimi, KILIAN EYERICH, Ming Tang, Thomas Haeufel, Christian Thoma, Diamant ThaçiThe above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite).
